Left atrial appendage closure with amplatzer cardiac plug for stroke prevention in atrial fibrillation: Initial Asia-Pacific experience

Catheterization and Cardiovascular Interventions

Volumn 79, Issue 5, 2012, Pages 794-800

  Lam, Yat Yin ^a   Yip, Gabriel W K ^a   Yu, Cheuk Man ^a   Chan, Wilson W M ^a   Cheng, Boron C W ^a   Yan, Bryan P ^a   Clugston, Richard ^b   Yong, Gerald ^b   Gattorna, Tim ^b   Paul, Vincent ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Amplatzer cardiac plug; Atrial fibrillation; Left atrial appendage occlusion; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PROPOFOL; WARFARIN;

AGED; AIR EMBOLISM; ANTICOAGULANT THERAPY; ARTICLE; CATHETER THROMBOSIS; CLINICAL ARTICLE; CLINICAL TRIAL; DEVICE SAFETY; DEVICE THERAPY; ENDOPROSTHESIS; ESOPHAGUS INJURY; FEMALE; FLUOROSCOPY; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HEPARINIZATION; HIGH RISK PATIENT; HUMAN; IMPLANTATION; INTRAVENOUS ADMINISTRATION; LEFT ATRIAL APPENDAGE CLOSURE; LENGTH OF STAY; LOADING DRUG DOSE; MALE; NON VALVULAR ATRIAL FIBRILLATION; SEPTAL OCCLUDER; STROKE; SURGICAL RISK; THROMBOGENESIS; THROMBOSIS; THROMBOSIS PREVENTION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

AGED; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; COHORT STUDIES; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEASIBILITY STUDIES; FEMALE; FLUOROSCOPY; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEPTAL OCCLUDER DEVICE; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84859441321     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.23136     Document Type: Article

References (16)

1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: The Framingham Study. Stroke 1991;22:983-988.
2. Gonzalez-Cruz I, Yan BP, Lam YY. Left atrial appendage exclusion: State-of-the art. Catheter Cardiovasc Interv 2010;75: 806-813.
3. Sievert H, Lesh MD, Trepels T, Omran H, Bartorelli A, Della Bella P, Nakai T, Reisman M, DiMario C, Block P, Kramer P, Fleschenberg D, Krumsdorf U, Scherer D. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: Early clinical experience. Circulation 2002;105:1887-1889. (Pubitemid 34437613)
4. Ostermayer SH, Reisman M, Kramer PH, Matthews RV, Gray WA, Block PC, Omran H, Bartorelli AL, Della Bella P, Di Mario C, Pappone C, Casale PN, Moses JW, Poppas A, Williams DO, Meier B, Skanes A, Teirstein PS, Lesh MD, Nakai T, Bayard Y, Billinger K, Trepels T, Krumsdorf U, Sievert H. Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. J Am Coll Cardiol 2005;46:9-14. (Pubitemid 40905122)
5. Sick PB, Schuler G, Hauptmann KE, Grube E, Yakubov S, Turi ZG, Mishkel G, Almany S, Holmes DR. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. J Am Coll Cardiol 2007;49:1490-1495. (Pubitemid 46505070)
6. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P, PROTECT AF Investigators. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 2009;374:534-544.
7. Block PC, Burstein S, Casale PN, Kramer PH, Teirstein P, Williams DO, Reisman M. Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: Five-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study. JACC Cardiovasc Interv 2009;2:594-600.
8. Park JW, Bethencour A, Sievert H, Santoro G, Meier B, Walsh K, Lopez-Minquez JR, Meerkin D, Valde M, Ormerod O, Leithäuser B. Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation - initial European Experience. Catheter Cardiovasc Interv 2011;77:700-706.
9. Rodés-Cabau J, Champagne J, Bernier M. Transcatheter closure of the left atrial appendage: Initial experience with the Amplatzer cardiac plug device. Catheter Cardiovasc Interv 2010;76:86-92.
10. Bass JL. Transcatheter occlusion of the left atrial appendage- experimental testing of a new Amplatzer device. Catheter Cardiovasc Interv 2010;76:181-185.
11. Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 2001;285: 2864-2870. (Pubitemid 32537350)
12. Bayard YL, Omran H, Neuzil P, Thuesen L, Pichler M, Rowland E, Ramondo A, Ruzyllo W, Budts W, Montalescot G, Brugada P, Serruys PW, Vahanian A, Piéchaud JF, Bartorelli A, Marco J, Probst P, Kuck KH, Ostermayer SH, Büscheck F, Fischer E, Leetz M, Sievert H. PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: Results from the European PLAATO study. EuroIntervention 2010;6:220-226.
13. Chan KC, Godman MJ, Walsh K, Wilson N, Redington A, Gibbs JL. Transcatheter closure of atrial septal defect and interatrial communications with a new self expanding nitinol double disc device (Amplatzer septal occluder): Multicentre UK experience. Heart 1999;82:300-306. (Pubitemid 29429601)
14. Cao QL, Du ZD, Joseph A, Koenig P, Heitschmidt M, Rhodes J, Hijazi ZM. Immediate and six-month results of the profile of the Amplatzer septal occluder as assessed by transesophageal echocardiography. Am J Cardiol 2001;88:754-759.
15. Meier B, Palacios I, Windecker S, Rotter M, Cao QL, Keane D, Ruiz CE, Hijazi ZM. Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation. Catheter Cardiovasc Interv 2003; 60:417-422. (Pubitemid 37356515)
16. Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S. Safety of percutaneous left atrial appendage closure: Results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients With AF (PROTECT AF) Clinical Trial and the Continued Access Registry. Circulation 2011;123: 417-424.